Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
90 studies found for:    Open Studies | "Pleural Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pleural Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion
Conditions: Pleural Diseases;   Infection
Intervention: Other: Chest physiotherapy
2 Recruiting Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study
Conditions: Pleural Effusion;   Pleural Diseases
Intervention: Device: cryobiopsy (Autoclavable cryoprobe 20416-032 (ERBE, Germany) Flexible FB-55CD-1 Olympus forceps
3 Recruiting Study of the Disease Process of Lymphangioleiomyomatosis
Conditions: Lung Disease;   Pneumothorax;   Tuberous Sclerosis
Intervention:
4 Recruiting Fortified Skimmed Mother's Milk in the Management of Chylothorax
Condition: Chylous Pleural Effusion Following Cardiothoracic Surgery
Interventions: Other: Skimmed mother's milk;   Other: Specialized Formula
5 Unknown  Use of Procalcitonin in the Diagnosis of Pleural Effusion
Condition: Pleural Effusion
Intervention:
6 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
7 Recruiting Pigtail Catheter: a Less Invasive Option for Pleural Drainage of Recurrent Hepatic Hydrothorax
Condition: Pleural Effusion
Intervention: Device: Pigtail catheter
8 Unknown  Pigtail Catheter Versus Chest Tube in the Management of Traumatic Pneumothorax
Condition: Traumatic Pneumothorax
Interventions: Device: Pigtail catheter insertion (Cook);   Device: chest tube (28-French)
9 Unknown  Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion
Condition: Pleural Effusion
Intervention:
10 Unknown  Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura.
Condition: Solitary Fibrous Tumors of the Pleura
Intervention:
11 Unknown  Angiogenic Cytokines and Fibrinolytic Activity in Parapneumonic Effusions
Condition: Pleural Effusion
Intervention: Device: pleural pigtail drainage
12 Recruiting Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion
Condition: Malignant Pleural Effusion
Interventions: Drug: Bevacizumab;   Drug: Pulvis talci
13 Recruiting Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Conditions: Kidney Neoplasms;   Kidney Cancer;   Pneumothorax;   FLCN Protien, Human
Intervention:
14 Not yet recruiting Using Ultrasound to Predict the Results of Draining Pleural Effusions
Condition: Pleural Effusion
Interventions: Other: Pleural Manometry;   Other: Thoracic ultrasonography;   Procedure: Pleural aspiration catheter OR chest drain (standard care);   Procedure: Talc slurry pleurodesis via chest drain (standard care)
15 Recruiting Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced
Conditions: Urethritis;   Cervicitis;   Genital Mycoplasma Infection;   Chlamydia Trachomatis
Interventions: Drug: Azithromycin;   Drug: Doxycycline;   Drug: lymecycline
16 Unknown  The First Therapeutic Intervention in Malignant Pleural Effusion Trial
Conditions: Malignant Pleural Effusion;   Pleural Effusion
Interventions: Other: Large bore chest drain + NSAID based analgesic regimen;   Other: Small bore chest drain + NSAID based analgesic regimen;   Other: Large bore chest drain + opiate based analgesic regimen;   Other: Small bore chest drain + opiate based analgesic regimen
17 Unknown  The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma
Conditions: Pleural Neoplasms;   Mesothelioma;   Pneumothorax;   Parathyroid Neoplasms;   Benign Tumor of the Thyroid;   Tumor of the Thyroid
Interventions: Other: Blood sampling;   Other: Control Group
18 Not yet recruiting Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Brenner Tumor;   Malignant Ascites;   Malignant Pleural Effusion;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Primary Peritoneal Cavity Cancer
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: docetaxel;   Drug: metformin hydrochloride;   Drug: placebo;   Other: laboratory biomarker analysis
19 Recruiting Disconnection Technique With a Bronchial Blocker for Improving Lung Deflation
Condition: Pneumothorax
Interventions: Procedure: DLT with conventional technique;   Procedure: BB with conventional technique;   Procedure: Disconnection technique
20 Recruiting Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Bevacizumab;   Drug: recombinant human endostatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years